Centene Corporation (CNC)
59.49 USD +1.68 (+2.91%) Volume: 5.81M
Centene Corporation’s stock price stands at 59.49 USD, marking an impressive trading session increase of +2.91%. Despite a year-to-date decrease of -19.75%, the robust trading volume of 5.81M showcases the stock’s potential. Explore CNC’s dynamic performance and investment opportunities.
Latest developments on Centene Corporation
Recent insider buying activities at Centene Corp (CNC) have caught the attention of investors, with directors like Christopher Coughlin and Theodore Samuels purchasing significant amounts of company stock. Despite underperforming compared to competitors on Tuesday, the stock managed to outperform them on other days, showing resilience in the face of losses. With notable acquisitions by MML Investors Services LLC and Sanctuary Advisors LLC, it seems that confidence in Centene remains strong. Analysts at JPMorgan Chase & Co. have reaffirmed an overweight rating, while Jefferies expresses concerns with an underperform rating. Director Dallas H. James and Jessica Blume also joined in on the buying spree, indicating a positive outlook for Centene Corp‘s stock price movement.
Centene Corporation on Smartkarma
Analysts on Smartkarma, like Baptista Research, are optimistic about Centene Corp. According to Baptista Research‘s report, titled “Centene Corporation: Operational Efficiency & AI Utilization Driving Our Optimism! – Major Drivers,” the company’s third-quarter financial results for 2024 exceeded expectations. Centene Corporation achieved an adjusted diluted EPS of $1.62, attributing the outperformance to realized tax benefits and accelerated income tax benefits. The report highlights the company’s nuanced performance, showcasing strengths and ongoing challenges within its operations.
A look at Centene Corporation Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 5 | |
Dividend | 1 | |
Growth | 5 | |
Resilience | 3 | |
Momentum | 3 | |
OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Centene Corporation, a multi-line managed care organization, is poised for a strong long-term outlook based on its Smartkarma Smart Scores. With top scores in Value and Growth, the company demonstrates solid fundamentals and potential for expansion. While its Dividend score is lower, Centene’s focus on providing Medicaid and Medicaid-related programs, along with specialty services like behavioral health, positions it well for future growth and success.
Although Centene Corp‘s Resilience and Momentum scores are moderate, its high scores in Value and Growth indicate a promising outlook. The company’s presence in multiple states and diverse range of health plans highlight its strong foundation in the healthcare industry. With a focus on innovation and providing essential healthcare services, Centene Corp is well-positioned to navigate challenges and capitalize on opportunities in the evolving healthcare landscape.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars